Tele: 561.316.3330
Breaking Medical Device News

Tuesday, September 21, 2021


HomeEXECUTIVESACRO Announces New Member and 2020 Officers

ACRO Announces New Member and 2020 Officers

The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected Alistair Macdonald, Chief Executive Officer of Syneos Health, as 2020 Chair. Steve Cutler, Chief Executive Officer of ICON, was elected Vice Chair. The Board of Directors also elected Jason Meggs, Chief Financial Officer at Syneos Health, as Treasurer, and Diarmaid Cunningham, Chief Administrative Officer & General Counsel at ICON, as Secretary.

With over 20 years of experience in the biopharmaceutical industry, Macdonald has led Syneos Health’s global expansion, implementing new technologies, processes and integrated solutions. Prior to the INC Research/inVentiv Health merger to become Syneos Health in 2017, he held numerous roles of increasing responsibility at INC Research including Head of Global Business Development and Marketing, Head of Alliances Development and Delivery teams, Head of Global Oncology, and President of Clinical Development Services. He assumed the INC Research Chief Executive Officer role in 2016.

“Traditional product development models are being redefined by new market realities. Working together across the sector, we have the unique opportunity to identify new ways to navigate the challenges of a more complex operating, regulatory and reimbursement environment,” said Macdonald. “I look forward to cross-collaboration with ACRO member companies and key stakeholders to drive innovation to speed therapies to patients.”

2019 ACRO achievements include the development of two white papers featuring insights and recommendations for further implementation of Risk-Based Monitoring and participation in various FDA public workshops and meetings. Anticipating the drafting of follow-on legislation to the 21st Century Cures Act (Cures 2.0), ACRO hosted a briefing with the Congressional Research and Development Caucus and continues its productive engagement with TransCelerate Biopharma Inc. through the CRO Forum.

ACRO is also announcing the onboarding of its newest member, Signant Health, its sixth technology member. Signant is focused on using technology to connect research programs to patients for clinical research and pharmaceutical development.


Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy